{
  "id": "f5a2e3dcaf7cb48e",
  "title": "Challenges for a crucial sickle cell treatment and the latest outlook for GLP-1s",
  "description": "This week on \"The Readout LOUD\": We discuss financial outlooks from Novo Nordisk and Eli Lilly, a closer look at why manufacturing problems have slowed the rollout of a crucial&#8230;",
  "content": "This week on \"The Readout LOUD\": We discuss financial outlooks from Novo Nordisk and Eli Lilly, a closer look at why manufacturing problems have slowed the rollout of a crucial&#8230;",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/02/05/readout-loud-podcast-sickle-cell-treatment-novo-nordisk-eli-lilly-outlook/?utm_campaign=rss",
  "published_at": "2026-02-05T20:52:05+00:00",
  "fetched_at": "2026-02-06T00:27:14.258190+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "manufacturing"
  ],
  "location": null,
  "raw_data": {
    "title": "Challenges for a crucial sickle cell treatment and the latest outlook for GLP-1s",
    "description": "This week on \"The Readout LOUD\": We discuss financial outlooks from Novo Nordisk and Eli Lilly, a closer look at why manufacturing problems have slowed the rollout of a crucial&#8230;",
    "url": "https://www.statnews.com/2026/02/05/readout-loud-podcast-sickle-cell-treatment-novo-nordisk-eli-lilly-outlook/?utm_campaign=rss",
    "published": "2026-02-05T20:52:05+00:00",
    "source": "STAT"
  }
}